NO870613L - Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre. - Google Patents

Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.

Info

Publication number
NO870613L
NO870613L NO870613A NO870613A NO870613L NO 870613 L NO870613 L NO 870613L NO 870613 A NO870613 A NO 870613A NO 870613 A NO870613 A NO 870613A NO 870613 L NO870613 L NO 870613L
Authority
NO
Norway
Prior art keywords
microorganisms
detection
nucleic acid
sample containing
containing nucleic
Prior art date
Application number
NO870613A
Other languages
English (en)
Other versions
NO870613D0 (no
Inventor
Nanibhushan Dattagupta
Peter M M Rae
Daniel U Rabin
Edward D Huguenel
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of NO870613D0 publication Critical patent/NO870613D0/no
Publication of NO870613L publication Critical patent/NO870613L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO870613A 1986-03-05 1987-02-17 Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre. NO870613L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83637886A 1986-03-05 1986-03-05
US94300686A 1986-12-29 1986-12-29

Publications (2)

Publication Number Publication Date
NO870613D0 NO870613D0 (no) 1987-02-17
NO870613L true NO870613L (no) 1987-09-07

Family

ID=27125866

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870613A NO870613L (no) 1986-03-05 1987-02-17 Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.

Country Status (9)

Country Link
EP (1) EP0235726B1 (no)
AU (1) AU599083B2 (no)
CA (1) CA1295535C (no)
DE (1) DE3785865T2 (no)
DK (1) DK112087A (no)
FI (1) FI870923A (no)
IL (1) IL81728A0 (no)
NO (1) NO870613L (no)
NZ (1) NZ219443A (no)

Families Citing this family (92)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1290664C (en) * 1986-03-05 1991-10-15 Nanibhushan Dattagupta Solution-phase single hybridization assay for detecting polynucleotide sequences
AU601021B2 (en) * 1987-03-11 1990-08-30 Molecular Diagnostics, Inc. Assay for necleic acid sequences in a sample
US5202231A (en) 1987-04-01 1993-04-13 Drmanac Radoje T Method of sequencing of genomes by hybridization of oligonucleotide probes
US6270961B1 (en) * 1987-04-01 2001-08-07 Hyseq, Inc. Methods and apparatus for DNA sequencing and DNA identification
JP2589729B2 (ja) * 1988-01-30 1997-03-12 極東製薬工業株式会社 染色体ｄｎａを用いた細菌の同定方法および該同定用キット
DE3804243A1 (de) * 1988-02-11 1989-08-24 Max Planck Gesellschaft Teils einzel- und teils doppelstraengige nukleinsaeuresonde und verfahren zu ihrer herstellung
GB8810400D0 (en) † 1988-05-03 1988-06-08 Southern E Analysing polynucleotide sequences
US5700637A (en) * 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) * 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US7811751B2 (en) 1988-05-03 2010-10-12 Oxford Gene Technology Limited Analysing polynucleotide sequences
US5047523A (en) * 1988-08-02 1991-09-10 Ortho Diagnostic Systems Inc. Nucleic acid probe for detection of neisseria gonorrhoea
US5324829A (en) * 1988-12-16 1994-06-28 Ortho Diagnostic Systems, Inc. High specific activity nucleic acid probes having target recognition and signal generating moieties
CA2005927A1 (en) * 1988-12-21 1990-06-21 Chander Bahl Method of preparing nucleotide probes using a bridging complement
US5514550A (en) * 1989-02-03 1996-05-07 Johnson & Johnson Clinical Diagnostics, Inc. Nucleic acid test article and its use to detect a predetermined nucleic acid
US5744101A (en) * 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
ATE94910T1 (de) * 1989-06-23 1993-10-15 Canon Kk Verfahren zum nachweis von nucleinsaeuren.
JP2802125B2 (ja) * 1989-06-23 1998-09-24 キヤノン株式会社 核酸の検出方法
DE3940597A1 (de) * 1989-12-08 1991-06-13 Bayer Ag Verfahren zur herstellung von di- und trialkyl-4'-phthalimidomethyl-furocumarinen
DE69112309T2 (de) * 1990-06-28 1996-01-25 Wakunaga Seiyaku Kk Verfahren zum Nukleinsäurenachweis.
EP1588761A3 (en) * 1991-11-22 2005-11-23 Affymetrix, Inc. Method of forming arrays of polymers
DE4212555A1 (de) * 1992-04-15 1993-10-21 Boehringer Mannheim Gmbh Verfahren zum Nachweis von Nukleinsäuren
EP0787183A4 (en) 1993-07-23 1998-05-27 Hyseq Inc METHOD FOR DETECTION OF UNKNOWN ORGANISMS
ES2097701B1 (es) * 1995-02-09 1997-11-16 Consejo Superior Investigacion Procedimiento para obtener sondas especificas de estirpe o de especie.
US6027879A (en) * 1995-08-09 2000-02-22 The Regents Of The University Of California Detection and isolation of nucleic acid sequences using a bifunctional hybridization probe
US5616465A (en) 1995-08-09 1997-04-01 The Regents Of The University Of California Detection and isolation of nucleic acid sequences using competitive hybridization probes
EP0880598A4 (en) 1996-01-23 2005-02-23 Affymetrix Inc RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM
US20020042048A1 (en) 1997-01-16 2002-04-11 Radoje Drmanac Methods and compositions for detection or quantification of nucleic acid species
US6297006B1 (en) 1997-01-16 2001-10-02 Hyseq, Inc. Methods for sequencing repetitive sequences and for determining the order of sequence subfragments
US6309824B1 (en) 1997-01-16 2001-10-30 Hyseq, Inc. Methods for analyzing a target nucleic acid using immobilized heterogeneous mixtures of oligonucleotide probes
ATE264523T1 (de) 1997-07-25 2004-04-15 Affymetrix Inc A Delaware Corp Verfahren zur herstellung einer bio-informatik- datenbank
US6420108B2 (en) 1998-02-09 2002-07-16 Affymetrix, Inc. Computer-aided display for comparative gene expression
US7068830B2 (en) 1997-07-25 2006-06-27 Affymetrix, Inc. Method and system for providing a probe array chip design database
US6826296B2 (en) 1997-07-25 2004-11-30 Affymetrix, Inc. Method and system for providing a probe array chip design database
US6355419B1 (en) 1998-04-27 2002-03-12 Hyseq, Inc. Preparation of pools of nucleic acids based on representation in a sample
US6306643B1 (en) 1998-08-24 2001-10-23 Affymetrix, Inc. Methods of using an array of pooled probes in genetic analysis
US6185561B1 (en) 1998-09-17 2001-02-06 Affymetrix, Inc. Method and apparatus for providing and expression data mining database
US6489096B1 (en) 1998-10-15 2002-12-03 Princeton University Quantitative analysis of hybridization patterns and intensities in oligonucleotide arrays
EP1294934A2 (en) 2000-03-08 2003-03-26 Complexe Hospitalier de la Sagamie Very low density lipoprotein receptor polymorphisms and uses therefor
AU2002247765B2 (en) 2001-03-28 2007-04-26 Clondiag Chip Technologies Gmbh Device for referencing fluorescence signals
DE10201463B4 (de) 2002-01-16 2005-07-21 Clondiag Chip Technologies Gmbh Reaktionsgefäß zur Durchführung von Array-Verfahren
CA2511012C (en) 2002-12-20 2018-02-27 Applera Corporation Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
EP2186913B1 (en) 2003-11-26 2016-02-10 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
EP2423326B1 (en) 2004-05-07 2014-01-08 Celera Corporation Genetic polymorphism associated with liver fibrosis methods of detection and uses thereof
US7858763B2 (en) 2004-06-04 2010-12-28 Council Of Scientific And Industrial Research Transforming growth factor beta 1 (TGFβ1) haplotypes and prediction of susceptibility for immunological disorders
AU2005307765C1 (en) 2004-11-16 2012-07-05 Trustees Of Boston University Roles for Dual Endothelin-1/Angiotensin II Receptor (DEAR) in hypertension and angiogenesis
JP2008529536A (ja) 2005-02-14 2008-08-07 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 加齢性黄斑変性を処置および診断するための方法および試薬
WO2006099365A2 (en) 2005-03-11 2006-09-21 Applera Corporation Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
US7595151B2 (en) 2005-07-01 2009-09-29 Arbor Vita Corporation Methods and compositions for diagnosis and treatment of influenza
US7799530B2 (en) 2005-09-23 2010-09-21 Celera Corporation Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
US7695911B2 (en) 2005-10-26 2010-04-13 Celera Corporation Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
EP2046807B1 (en) 2006-07-13 2012-03-28 University of Iowa Research Foundation Methods and reagents for treatment and diagnosis of vascular disorders and age-related macular degeneration
US7993833B2 (en) 2006-09-11 2011-08-09 Celera Corporation Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
CA2666346C (en) 2006-10-20 2016-02-23 Celera Corporation Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
EP2183386A1 (en) 2007-05-31 2010-05-12 Yale University A genetic lesion associated with cancer
EP2952588A1 (en) 2007-08-06 2015-12-09 Orion Genomics, LLC Single nucleotide polymorphism in igf2 for determining the allele-specific expression of the igf2 gene
US8039212B2 (en) 2007-11-05 2011-10-18 Celera Corporation Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
EP2065474A1 (en) 2007-11-28 2009-06-03 Siemens Healthcare Diagnostics GmbH A method to assess prognosis and to predict therapeutic response to endocrine treatment
US20090221620A1 (en) 2008-02-20 2009-09-03 Celera Corporation Gentic polymorphisms associated with stroke, methods of detection and uses thereof
WO2009140685A2 (en) 2008-05-16 2009-11-19 Bristol-Myers Squibb Company Methods for identifying subjects with an increased likelihood of responding to dpp-iv inhibitors
EP3093351B1 (en) 2008-07-09 2018-04-18 Celera Corporation Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
AU2010213727A1 (en) 2009-02-11 2011-09-29 Orion Genomics Llc Combinations of polymorphisms for determining allele-specific expression of IGF2
WO2010151841A2 (en) 2009-06-25 2010-12-29 Yale University Single nucleotide polymorphisms in brca1 and cancer risk
US20110104154A1 (en) 2009-10-30 2011-05-05 Alcon Research, Ltd. Single nucleotide polymorphisms and genes associated with age-related macular degeneration
WO2011128096A1 (en) 2010-04-16 2011-10-20 Roche Diagnostics Gmbh Polymorphism markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
US20110269735A1 (en) 2010-04-19 2011-11-03 Celera Corporation Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
US20140004510A1 (en) 2010-09-24 2014-01-02 Massachusetts Eye And Ear Infirmary Methods and compositions for prognosing and/or detecting age-related macular degeneration
US20120108651A1 (en) 2010-11-02 2012-05-03 Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
KR20140064924A (ko) 2011-08-31 2014-05-28 에프. 호프만-라 로슈 아게 항-혈관신생 치료와 연관된 고혈압 위험성의 예측 방법
MX2014002311A (es) 2011-08-31 2014-08-26 Hoffmann La Roche Capacidad de respuesta a inhibidores de angiogenesis.
WO2013059884A1 (en) 2011-10-28 2013-05-02 Itek Ventures Pty Ltd A gene and mutations thereof associated with seizure and movement disorders
CA2854568A1 (en) 2011-11-23 2013-05-30 Life Sciences Research Partners Vzw Responsiveness to angiogenesis inhibitors
EP2827701B1 (en) 2012-03-19 2020-11-18 Malaysian Palm Oil Board Gene controlling shell phenotype in palm
US10294529B2 (en) 2012-04-10 2019-05-21 Life Sciences Research Partners Vzw Microsatellite instability markers in detection of cancer
US10633707B2 (en) 2012-04-10 2020-04-28 Vib Vzw Markers for detecting microsatellite instability in cancer and determining synthetic lethality with inhibition of the DNA base excision repair pathway
GB201417499D0 (en) 2014-10-03 2014-11-19 Convergence Pharmaceuticals Novel use
GB201417500D0 (en) 2014-10-03 2014-11-19 Convergence Pharmaceuticals Novel use
GB201417497D0 (en) 2014-10-03 2014-11-19 Convergence Pharmaceuticals Novel use
EP3218515B1 (en) 2014-11-10 2023-04-26 F. Hoffmann-La Roche AG Therapeutic and diagnostic methods for il-33-mediated disorders
US11884983B2 (en) 2014-11-18 2024-01-30 Aqua Gen As Method for predicting resistance
JP6858783B2 (ja) 2015-10-18 2021-04-14 アフィメトリックス インコーポレイテッド 一塩基多型及びインデルの複対立遺伝子遺伝子型決定
AU2017207341A1 (en) 2016-01-12 2018-08-02 Interleukin Genetics, Inc. Methods for predicting response to treatment
WO2017182623A1 (en) 2016-04-22 2017-10-26 Aquagen As A qtl for omega-3 fatty acid content in fish
CA3031222A1 (en) 2016-06-29 2018-01-04 Tine Sa Quantitative trait loci affecting fatty acid composition in milk
US10329620B2 (en) 2017-01-12 2019-06-25 Cardioforecast Ltd. Methods and kits for treating cardiovascular disease
WO2019157358A1 (en) 2018-02-09 2019-08-15 Genentech, Inc. Therapeutic and diagnostic methods for mast cell-mediated inflammatory diseases
US20220249660A1 (en) 2019-06-06 2022-08-11 Sitokine Limited Compositions and methods for treating lung, colorectal and breast cancer
WO2021028469A1 (en) 2019-08-12 2021-02-18 Sitokine Limited Compositions and methods for treating cytokine release syndrome and neurotoxicity
ES2903351T3 (es) 2019-12-18 2022-04-01 Aquagen As Maduración sexual en trucha arco iris
US20230110203A1 (en) 2020-03-13 2023-04-13 Medimmune Limited Therapeutic methods for the treatment of subjects with risk alelles in il33
WO2021205013A1 (en) 2020-04-09 2021-10-14 Sitokine Limited Compositions and methods for treating covid-19

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4358535A (en) * 1980-12-08 1982-11-09 Board Of Regents Of The University Of Washington Specific DNA probes in diagnostic microbiology
US4446237A (en) * 1981-03-27 1984-05-01 Life Technologies, Inc. Method for detection of a suspect viral deoxyribonucleic acid in an acellular biological fluid
US4395486A (en) * 1981-08-19 1983-07-26 Medical College Of Ga. Research Inst., Inc. Method for the direct analysis of sickle cell anemia
CA1222680A (en) * 1983-07-05 1987-06-09 Nanibhushan Dattagupta Testing dna samples for particular nucleotide sequences
CA1338856C (en) * 1983-07-05 1997-01-21 Jannis Stavrianopoulos In vivo labelling of polynucleotide sequences
US4737454A (en) * 1983-07-14 1988-04-12 Molecular Diagnostics, Inc. Fast photochemical method of labelling nucleic acids for detection purposes in hybridization assays
FR2588383B1 (fr) * 1985-10-04 1988-01-08 Inst Nat Sante Rech Med Nouveau procede de recuperation et de dosage de microquantites d'acide desoxyribonucleique dans un liquide biologique acellulaire
CA1290664C (en) * 1986-03-05 1991-10-15 Nanibhushan Dattagupta Solution-phase single hybridization assay for detecting polynucleotide sequences
NO870614L (no) * 1986-03-06 1987-09-07 Molecular Diagnostics Inc Rask dna-pŸvisning av mikrober.

Also Published As

Publication number Publication date
AU6972387A (en) 1987-09-10
NZ219443A (en) 1990-01-29
FI870923A0 (fi) 1987-03-03
DK112087D0 (da) 1987-03-04
EP0235726A3 (en) 1989-05-10
EP0235726B1 (en) 1993-05-19
CA1295535C (en) 1992-02-11
DE3785865T2 (de) 1993-08-26
FI870923A (fi) 1987-09-06
IL81728A0 (en) 1987-10-20
DK112087A (da) 1987-09-06
NO870613D0 (no) 1987-02-17
EP0235726A2 (en) 1987-09-09
DE3785865D1 (de) 1993-06-24
AU599083B2 (en) 1990-07-12

Similar Documents

Publication Publication Date Title
NO870613L (no) Deteksjon av mikroorganismer i en prŸve inneholdende nukleinsyre.
AU7015287A (en) Detection of nucleic acid sequence using liquid hybridization method
EP0133671A3 (en) Detection of bacteria by nucleic acid hybridization, labeled probes and test kit therefore
BE875598A (fr) Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique utilise
DE3767755D1 (de) Mikrobiologische entschwefelung von gasen.
DE3875667D1 (de) Menschliche papillomavirusnukleinsaeureproben.
KR890700227A (ko) 효소 센서
DE3481775D1 (de) Verfahren zum raschen nachweis von mikroorganismen in klinischen proben.
DE3765446D1 (de) Uebertragungsmaterial von musterungen.
DE3779706D1 (de) Enzymsensor zur bestimmung von glutaminat-konzentration.
DE3751190D1 (de) Sauerstoffkonzentrationsfühler.
IL81695A0 (en) Quantitative determination of nucleic acid molecules and the reagent kit used
DE3671918D1 (de) Nukleinsaeure sequenzanalyse durch hemmung von exonuklease.
DE3677916D1 (de) Nachweis von retikulozyten.
DE3673928D1 (de) Nachweis von retikulocyten.
AU1049988A (en) Non-radioactive nucleic acid probes
NO870614L (no) Rask dna-pŸvisning av mikrober.
ZA871554B (en) Detection of microroganisms in a nucleic acid containing sample
DE3686893D1 (de) Gaerung zur gewinnung von d-milchsaeure.
GB8705957D0 (en) Nucleic acid assay
DK590587A (da) Detektion af nucleinsyre-hybrider
DE3780855D1 (de) Zellkultur-methode.
DE3770206D1 (de) Schnellnachweis von n.-gonorrhoe ohne kultur.
FI853641L (fi) Anvaendning av vattenloesliga polymerer i vattenhaltiga kompositioner av kemiskt ljus.
DE3679298D1 (de) Herstellung von tabletten aus mikrobiologischen substanzen.